Regulatory Intelligence · Analysis · Advocacy
Iota Intel turns dense federal and state rulemaking into clear, actionable analysis — and, while the window is open, into comment letters regulators are required to consider. Food, environment, health, consumer products, privacy, trade: the through-line isn't a sector. It's method.
Most regulatory help arrives too late or too vague. We work the rule on the timeline that matters — while you can still influence it, and after it binds you.
A close legal read of a proposed pesticide-tolerance rule — tested against the FFDCA "reasonable certainty of no harm" standard, the agency's duty to respond to significant comments, and the narrowed deference landscape after Loper Bright and Relentless.
An implementation analysis of a rule executing a specific statutory mandate (MoCRA § 3505) — mapping the testing methodology, phase-in, small-business compliance path, and where the agency's record is strongest.
A constructive, build-it-this-way comment: a workable definition, a tiered disclosure approach, and integration with existing federal data systems — the kind of input an agency can actually operationalize.
Where burden can be cut and where it can't — principles and targeted recommendations balancing compliance cost against measurable risk, with attention to small manufacturers and import certification.
A fully sourced comment on the agency's draft CCL 6 — a 34-footnote evidentiary framework, framed for durability in the post–Loper Bright environment.
A comment grounded in global FHIR-adoption evidence and a voluntary industry pledge — pairing U.S. rulemaking with international benchmarking to test what the standard can realistically achieve.
Every letter is written to be transferable — a model a client can adapt and file under their own name or letterhead. That reusable approach is the core of how we work.
The same discipline that reads a federal rule reads a market-entry pathway or a benefits-compliance question. Two areas where it's especially useful:
Building the regulatory approach and justification to bring a product into a new jurisdiction — mapping the pathway, the evidence a regulator will expect, and the argument that gets you there. For in-country submissions we team with local specialists; we bring the strategy and the regulatory reasoning.
Employers and brokers carry real compliance and fiduciary duties — but rely on insurers and TPAs to administer them. We help you ask the right questions of your TPA, and judge the answers, so "we're aware of the law and studying it" isn't where the conversation ends. Built from experience inside a national health enterprise.
Who's behind Iota Intel
Iota Intel is led by Bradley Shogren, who has worked regulation from nearly every side — drafting comments to agencies, and interpreting and complying with rules inside one of the nation's largest health enterprises, through the director level. That sits on top of an earlier career in international business and cross-border trade, with its own legal, regulatory, and commercial dimensions. The range is the point: the method that reads a drinking-water rule reads a device-market pathway or a benefits-compliance question just as well.
The first step toward solving a complex challenge begins with a conversation.